← Back to Search

Tablet based interactive diabetes education modules for Type 1 Diabetes

N/A
Waitlist Available
Led By Steven Ghanny, MD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up test will be completed on day 3 (+/- 2 days)
Awards & highlights

Study Summary

This trial will compare standard diabetes education to education accessed through a bedside tablet.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~test will be completed on day 3 (+/- 2 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and test will be completed on day 3 (+/- 2 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness of tablet education in newly diagnosed type 1 diabetes
Secondary outcome measures
Improved subject compliance with glucose monitoring

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group 2Experimental Treatment2 Interventions
Participants randomized to Group 2 will receive Molly Center Standard Diabetes Education plus access to Tablet based interactive diabetes education modules
Group II: Group 1Experimental Treatment1 Intervention
Participants randomized to Group 1 will receive Standard Diabetic Education with Registered Nurse and Molly Center Diabetes Care Guide (paper-based)

Find a Location

Who is running the clinical trial?

Verizon FoundationOTHER
3 Previous Clinical Trials
383 Total Patients Enrolled
Hackensack Meridian HealthLead Sponsor
131 Previous Clinical Trials
28,194 Total Patients Enrolled
Steven Ghanny, MDPrincipal InvestigatorJoseph M.Sanzari Children's Hospital at Hackensack University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes
2017. "Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03534193.
~6 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top